Industry Overview

US mammography market was valued at $1.3 billion in 2025 and is projected to reach $3.5 million by 2035, growing at a CAGR of 10.7% during the forecast period (2026–2035). The US mammography market is experiencing steady growth, supported by the continued emphasis on routine screening and early-stage diagnosis across the healthcare system. Increasing utilization of advanced imaging technologies is contributing to improved diagnostic outcomes and higher adoption across medical facilities. The presence of well-established healthcare providers and ongoing investments in imaging infrastructure further support market expansion. In addition, favorable reimbursement policies encourage the use of screening procedures, strengthening demand for related equipment. Continuous technological advancements are enhancing efficiency and accuracy, reinforcing their clinical value. These combined factors are contributing to sustained development within the market.

Market Dynamics

Increasing Adoption of Advanced Breast Imaging Systems

The US market is witnessing a steady transition toward advanced imaging technologies that offer improved diagnostic clarity and operational efficiency. Healthcare providers are gradually upgrading existing equipment to systems capable of delivering more precise and detailed results. This shift is supported by the need to enhance early detection rates and reduce diagnostic uncertainties. Leading manufacturers continue to introduce incremental innovations, focusing on usability and performance improvements. The presence of structured screening programs further supports consistent demand for such systems. As a result, adoption of technologically advanced solutions continues to strengthen across healthcare facilities.

Expansion of Screening Access Across Care Settings

Another notable trend is the widening availability of screening services beyond traditional hospital environments into outpatient and specialized diagnostic centers. This shift is enabling broader patient access and more convenient screening options. Healthcare networks are increasingly investing in distributed imaging capabilities to improve service coverage and reduce patient wait times. Market participants are responding by offering flexible and scalable solutions tailored to different care settings. Additionally, collaborations between healthcare providers are helping extend screening services to underserved areas. This ongoing expansion is contributing to sustained utilization and market growth.

Market Segmentation

• Based on the product type, the market is segmented into digital systems, analog systems, biopsy systems, film screen systems, and others.
• Based on the end-users, the market is segmented into hospital & clinics and diagnostic centers.

Digital Systems Segment to Lead the Market with the Largest Share

Demand for advanced imaging equipment continues to rise as healthcare providers prioritize accuracy and efficiency in diagnostic procedures. Digital systems are increasingly preferred due to their ability to deliver faster image acquisition and improved visualization quality. Ongoing replacement of conventional equipment is supporting steady demand, particularly in developed healthcare settings. Major industry participants such as Hologic, GE HealthCare, and Siemens Healthineers are focusing on continuous product refinement to strengthen their competitive positioning. Recent developments highlight integration with enhanced image processing capabilities, supporting more reliable clinical outcomes. These factors collectively contribute to sustained expansion within this segment.

Diagnostic Centers: A Key Segment in Market Growth

Diagnostic centers are gaining importance as they provide accessible and specialized imaging services outside traditional hospital environments. Growth in this segment is supported by increasing patient preference for quicker and more convenient diagnostic solutions. Operators are investing in modern equipment to improve service quality and manage higher patient volumes efficiently. Key market participants are targeting this segment with adaptable product offerings suited to varying operational needs. Recent trends indicate a gradual shift toward decentralized care delivery models, enhancing service reach. This transition is expected to support continued growth and strengthen the segment’s contribution to overall market development.

Market Players Outlook

The major companies operating in the US mammography market include Hologic, Inc., GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., and FUJIFILM Holdings Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In April 2025, GE HealthCare Technologies Inc. expanded its mammography portfolio in the U.S. by introducing advancements to its Pristina Via mammography system and commercially distributing the AI-enabled SmartMammo solution. The launch integrates AI into breast imaging workflows to enhance diagnostic accuracy and streamline radiology processes, reflecting continued product innovation in the U.S. market.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• US-wise analysis of major geographical regions.
• Key companies operating in the US mammography market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.